Evidence map›Paper›PMID 18771595›Full record

ArticleBMC molecular biology2008

Phi29 polymerase based random amplification of viral RNA as an alternative to random RT-PCR.

Nicolas Berthet, Anita K Reinhardt, India Leclercq, Sven van Ooyen, Christophe Batéjat, Philip Dickinson, Rayna Stamboliyska, Iain G Old, Katherine A Kong, Laurent Dacheux and 5 more

Open access · hybridAbstract readComparative StudyEvaluation Study
In one paragraph

Article in BMC molecular biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 80 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Viral metagenomics and blood safety.Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine · 2016
    Review
  18. Article
  19. Article
  20. Viral diversity in swine intestinal mucus used for the manufacture of heparin as analyzed by high-throughput sequencing.Biologicals : journal of the International Association of Biological Standardization · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Nicolas Berthet1Genotyping of Pathogens and Public Health Technological Platform, Institut Pasteur, Paris, France. nberthet@pasteur.fr
Anita K Reinhardt
India Leclercq
Sven van Ooyen
Christophe Batéjat
Philip Dickinson
Rayna Stamboliyska
Iain G Old
Katherine A Kong
Laurent Dacheux
Hervé Bourhy
Giulia C Kennedy
Christian Korfhage
Stewart T Cole
Jean-Claude Manuguerra
Institut Pasteur · FRQiagen (Germany) · DE

Funding

Pathogen and Genetic Element Detection Using MicroarraysUC1AI062613 · NIAID · AFFYMETRIX, INC. · PI KENNEDY, GUILIA C · 2004 to 2004
$2.1M
NIAID NIH HHS AI062613NIAID NIH HHS UC1 AI062613
6 · The paper itself

Abstract

backgroundPhi29 polymerase based amplification methods provides amplified DNA with minimal changes in sequence and relative abundance for many biomedical applications. RNA virus detection using microarrays, however, can present a challenge because phi29 DNA polymerase cannot amplify RNA nor small cDNA fragments (<2000 bases) obtained by reverse transcription of certain viral RNA genomes. Therefore, ligation of cDNA fragments is necessary prior phi29 polymerase based amplification. We adapted the QuantiTect Whole Transcriptome Kit (Qiagen) to our purposes and designated the method as Whole Transcriptome Amplification (WTA).

resultsWTA successfully amplified cDNA from a panel of RNA viruses representing the diversity of ribovirus genome sizes. We amplified a range of genome copy numbers from 15 to 4 x 10(7) using WTA, which yielded quantities of amplified DNA as high as 1.2 microg/microl or 10(10) target copies. The amplification factor varied between 10(9) and 10(6). We also demonstrated that co-amplification occurred when viral RNA was mixed with bacterial DNA.

conclusionThis is the first report in the scientific literature showing that a modified WGA (WTA) approach can be successfully applied to viral genomic RNA of all sizes. Amplifying viral RNA by WTA provides considerably better sensitivity and accuracy of detection compared to random RT-PCR.

Indexed as

DNA-Directed DNA PolymeraseBacillus PhagesBase SequenceDNA, BacterialDNA PrimersGene Expression ProfilingGenome, ViralGenomicsNucleic Acid Amplification TechniquesOligonucleotide Array Sequence AnalysisReverse Transcriptase Polymerase Chain ReactionRift Valley fever virusRNA, ViralRNA VirusesStaphylococcus aureusDNA, BacterialDNA-Directed DNA PolymeraseDNA PrimersRNA, Viral

Identifiers

PMID18771595
PMCPMC2535778
OpenAlexW1976821076

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.